BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15589839)

  • 1. Influence of a mitochondrial genetic defect on capacitative calcium entry and mitochondrial organization in the osteosarcoma cells.
    Szczepanowska J; Zabłocki K; Duszyński J
    FEBS Lett; 2004 Dec; 578(3):316-22. PubMed ID: 15589839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) with a T-to-C point mutation at nt 8993 of mitochondrial DNA].
    Mitani M; Jinnai K; Takahashi K; Koide R; Tsuji S
    Rinsho Shinkeigaku; 2000 Jun; 40(6):600-4. PubMed ID: 11086401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NARP (neurogenic muscle weakness, ataxia and retinitis pigmentosa)].
    Goto Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):164-5. PubMed ID: 11596355
    [No Abstract]   [Full Text] [Related]  

  • 4. Organization and dynamics of human mitochondrial DNA.
    Legros F; Malka F; Frachon P; Lombès A; Rojo M
    J Cell Sci; 2004 Jun; 117(Pt 13):2653-62. PubMed ID: 15138283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NARP syndrome--a less known mitochondrial disease].
    Kuusisto H; Simola KO; Keränen T
    Duodecim; 2003; 119(16):1563-6. PubMed ID: 14535029
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytoskeletal structure of myoblasts with the mitochondrial DNA 3243A-->G mutation and of osteosarcoma cells with respiratory chain deficiency.
    Rusanen H; Annunen J; Ylä-Outinen H; Laurila A; Peltonen J; Hassinen IE; Majamaa K
    Cell Motil Cytoskeleton; 2002 Nov; 53(3):231-8. PubMed ID: 12211104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations.
    Fujita Y; Ito M; Nozawa Y; Yoneda M; Oshida Y; Tanaka M
    Mitochondrion; 2007; 7(1-2):80-8. PubMed ID: 17276738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NARP syndrome in a patient harbouring an insertion in the MT-ATP6 gene that results in a truncated protein.
    López-Gallardo E; Solano A; Herrero-Martín MD; Martínez-Romero I; Castaño-Pérez MD; Andreu AL; Herrera A; López-Pérez MJ; Ruiz-Pesini E; Montoya J
    J Med Genet; 2009 Jan; 46(1):64-7. PubMed ID: 19124644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load.
    Enns GM; Bai RK; Beck AE; Wong LJ
    Mol Genet Metab; 2006 Aug; 88(4):364-71. PubMed ID: 16546428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selenite on basic mitochondrial function in human osteosarcoma cells with chronic mitochondrial stress.
    Wojewoda M; Duszyński J; Więckowski M; Szczepanowska J
    Mitochondrion; 2012 Jan; 12(1):149-55. PubMed ID: 21742063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated late-onset cone-rod dystrophy revealing a familial neurogenic muscle weakness, ataxia, and retinitis pigmentosa syndrome with the T8993G mitochondrial mutation.
    Porto FB; Mack G; Sterboul MJ; Lewin P; Flament J; Sahel J; Dollfus H
    Am J Ophthalmol; 2001 Dec; 132(6):935-7. PubMed ID: 11730668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families].
    Tesarová M; Hansíková H; Hlavatá A; Klement P; Houst'ková H; Houstĕk J; Zeman J
    Cas Lek Cesk; 2002 Aug; 141(17):551-4. PubMed ID: 12404959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of heteroplasmic mitochondrial DNA (mtDNA) from a patient with NARP into two human rho degrees cell lines is associated either with selection and maintenance of NARP mutant mtDNA or failure to maintain mtDNA.
    Vergani L; Rossi R; Brierley CH; Hanna M; Holt IJ
    Hum Mol Genet; 1999 Sep; 8(9):1751-5. PubMed ID: 10441339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Aβ exposure augments mCa2+-independent mROS-mediated depletion of cardiolipin for the shift of a lethal transient mitochondrial permeability transition to its permanent mode in NARP cybrids: a protective targeting of melatonin.
    Hsiao CW; Peng TI; Peng AC; Reiter RJ; Tanaka M; Lai YK; Jou MJ
    J Pineal Res; 2013 Jan; 54(1):107-25. PubMed ID: 24446866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia.
    Parfait B; de Lonlay P; von Kleist-Retzow JC; Cormier-Daire V; Chrétien D; Rötig A; Rabier D; Saudubray JM; Rustin P; Munnich A
    Eur J Pediatr; 1999 Jan; 158(1):55-8. PubMed ID: 9950309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome and cytoskeleton responses in osteosarcoma cells with reduced OXPHOS activity.
    Annunen-Rasila J; Ohlmeier S; Tuokko H; Veijola J; Majamaa K
    Proteomics; 2007 Jun; 7(13):2189-200. PubMed ID: 17533645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NARP mutation and mtDNA depletion trigger mitochondrial biogenesis which can be modulated by selenite supplementation.
    Wojewoda M; Duszyński J; Szczepanowska J
    Int J Biochem Cell Biol; 2011 Aug; 43(8):1178-86. PubMed ID: 21550418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mtDNA T8993G mutation-induced mitochondrial complex V inhibition augments cardiolipin-dependent alterations in mitochondrial dynamics during oxidative, Ca(2+), and lipid insults in NARP cybrids: a potential therapeutic target for melatonin.
    Peng TI; Hsiao CW; Reiter RJ; Tanaka M; Lai YK; Jou MJ
    J Pineal Res; 2012 Jan; 52(1):93-106. PubMed ID: 21812817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of neurologic muscle weakness, ataxia, and retinitis pigmentosa (NARP) syndrome with a novel mitochondrial mutation m.8729 G>A].
    Miyawaki T; Koto S; Ishihara H; Goto Y; Nishino I; Kanda F; Toda T
    Rinsho Shinkeigaku; 2015; 55(2):91-5. PubMed ID: 25746071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants.
    Mattiazzi M; Vijayvergiya C; Gajewski CD; DeVivo DC; Lenaz G; Wiedmann M; Manfredi G
    Hum Mol Genet; 2004 Apr; 13(8):869-79. PubMed ID: 14998933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.